| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 31 | 2024 | 204 | 8.510 |
Why?
|
| Education, Medical | 9 | 2023 | 244 | 2.260 |
Why?
|
| Education, Medical, Undergraduate | 8 | 2023 | 179 | 2.200 |
Why?
|
| Anatomy | 5 | 2017 | 21 | 2.170 |
Why?
|
| Mesothelioma | 14 | 2024 | 327 | 1.900 |
Why?
|
| Radiologists | 6 | 2022 | 50 | 1.820 |
Why?
|
| Curriculum | 15 | 2022 | 576 | 1.730 |
Why?
|
| Students, Medical | 10 | 2022 | 427 | 1.710 |
Why?
|
| Tomography, X-Ray Computed | 23 | 2024 | 2708 | 1.370 |
Why?
|
| Educational Measurement | 8 | 2017 | 234 | 1.350 |
Why?
|
| Internship and Residency | 7 | 2022 | 1073 | 1.270 |
Why?
|
| Pleural Neoplasms | 10 | 2024 | 204 | 1.230 |
Why?
|
| Teaching | 4 | 2014 | 146 | 1.230 |
Why?
|
| Radiography | 8 | 2024 | 808 | 1.110 |
Why?
|
| Formative Feedback | 2 | 2023 | 14 | 0.960 |
Why?
|
| Schools, Medical | 5 | 2023 | 137 | 0.930 |
Why?
|
| Diagnostic Imaging | 5 | 2017 | 476 | 0.910 |
Why?
|
| Surveys and Questionnaires | 10 | 2022 | 2699 | 0.750 |
Why?
|
| Burnout, Professional | 2 | 2020 | 103 | 0.710 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 183 | 0.700 |
Why?
|
| Personnel Selection | 2 | 2017 | 62 | 0.660 |
Why?
|
| Career Choice | 2 | 2017 | 150 | 0.610 |
Why?
|
| Computer-Assisted Instruction | 3 | 2014 | 44 | 0.610 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 130 | 0.600 |
Why?
|
| Workload | 1 | 2019 | 129 | 0.590 |
Why?
|
| Communication | 2 | 2021 | 462 | 0.590 |
Why?
|
| Mentoring | 1 | 2018 | 33 | 0.580 |
Why?
|
| Radiology Department, Hospital | 2 | 2016 | 24 | 0.580 |
Why?
|
| Humans | 74 | 2024 | 91222 | 0.570 |
Why?
|
| United States | 18 | 2022 | 7203 | 0.550 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 652 | 0.530 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 407 | 0.510 |
Why?
|
| Lung Neoplasms | 9 | 2022 | 2389 | 0.500 |
Why?
|
| Needs Assessment | 1 | 2015 | 158 | 0.450 |
Why?
|
| Biomedical Research | 1 | 2018 | 401 | 0.450 |
Why?
|
| Illusions | 1 | 2013 | 13 | 0.440 |
Why?
|
| Organizational Objectives | 1 | 2013 | 24 | 0.420 |
Why?
|
| Models, Educational | 1 | 2013 | 49 | 0.410 |
Why?
|
| Classification | 1 | 2013 | 54 | 0.410 |
Why?
|
| Faculty | 1 | 2013 | 34 | 0.410 |
Why?
|
| Dizziness | 1 | 2012 | 26 | 0.400 |
Why?
|
| Artifacts | 2 | 2013 | 246 | 0.400 |
Why?
|
| Vertigo | 1 | 2012 | 41 | 0.390 |
Why?
|
| Cadaver | 1 | 2012 | 187 | 0.390 |
Why?
|
| Forecasting | 1 | 2013 | 308 | 0.380 |
Why?
|
| Physicians | 1 | 2019 | 689 | 0.380 |
Why?
|
| Visual Perception | 1 | 2013 | 328 | 0.340 |
Why?
|
| Airway Resistance | 3 | 2000 | 70 | 0.340 |
Why?
|
| Ultrasonography | 4 | 2016 | 722 | 0.310 |
Why?
|
| Male | 37 | 2024 | 43371 | 0.290 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 536 | 0.290 |
Why?
|
| Learning | 2 | 2023 | 290 | 0.280 |
Why?
|
| Female | 37 | 2024 | 47276 | 0.280 |
Why?
|
| Clinical Competence | 3 | 2018 | 801 | 0.270 |
Why?
|
| Models, Biological | 1 | 2013 | 1772 | 0.260 |
Why?
|
| Lung | 5 | 2015 | 1325 | 0.250 |
Why?
|
| Middle Aged | 30 | 2024 | 26615 | 0.250 |
Why?
|
| Computer Security | 1 | 2024 | 18 | 0.230 |
Why?
|
| Feedback | 2 | 2023 | 137 | 0.230 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 35 | 0.220 |
Why?
|
| Radiographic Image Enhancement | 3 | 2015 | 466 | 0.210 |
Why?
|
| Neoplasm Staging | 5 | 2022 | 2024 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 27 | 0.200 |
Why?
|
| Aged | 25 | 2024 | 19601 | 0.200 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 6843 | 0.200 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 2787 | 0.200 |
Why?
|
| Radiography, Thoracic | 3 | 2014 | 329 | 0.200 |
Why?
|
| Adult | 20 | 2018 | 27209 | 0.200 |
Why?
|
| Advisory Committees | 1 | 2022 | 91 | 0.200 |
Why?
|
| Data Collection | 2 | 2014 | 377 | 0.190 |
Why?
|
| Ascites | 1 | 2022 | 56 | 0.190 |
Why?
|
| Phrenic Nerve | 2 | 2000 | 43 | 0.190 |
Why?
|
| Diaphragm | 3 | 2000 | 54 | 0.180 |
Why?
|
| Pilot Projects | 3 | 2019 | 890 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1748 | 0.180 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2022 | 100 | 0.180 |
Why?
|
| Intubation, Intratracheal | 2 | 2000 | 150 | 0.170 |
Why?
|
| Magnetics | 2 | 1997 | 41 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 2 | 2011 | 57 | 0.170 |
Why?
|
| Virtual Reality | 1 | 2020 | 28 | 0.160 |
Why?
|
| Algorithms | 4 | 2015 | 1938 | 0.160 |
Why?
|
| Mediastinum | 1 | 2019 | 48 | 0.160 |
Why?
|
| Medical Records | 1 | 2019 | 120 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2011 | 1266 | 0.150 |
Why?
|
| Documentation | 1 | 2019 | 103 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 353 | 0.150 |
Why?
|
| Work of Breathing | 1 | 1998 | 5 | 0.150 |
Why?
|
| Angiography | 2 | 2014 | 200 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2020 | 3504 | 0.150 |
Why?
|
| Ventilator Weaning | 1 | 1998 | 25 | 0.150 |
Why?
|
| Respiratory Function Tests | 2 | 2017 | 145 | 0.140 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2000 | 218 | 0.140 |
Why?
|
| Psychometrics | 1 | 2019 | 332 | 0.140 |
Why?
|
| Mammary Analogue Secretory Carcinoma | 1 | 2017 | 4 | 0.140 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 255 | 0.140 |
Why?
|
| Streptococcus agalactiae | 1 | 1997 | 11 | 0.140 |
Why?
|
| Arthritis, Infectious | 1 | 1997 | 17 | 0.140 |
Why?
|
| Observer Variation | 3 | 2013 | 615 | 0.140 |
Why?
|
| Tumor Burden | 4 | 2024 | 312 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 1997 | 55 | 0.140 |
Why?
|
| Arthritis, Psoriatic | 1 | 1997 | 34 | 0.140 |
Why?
|
| Guidelines as Topic | 2 | 2015 | 163 | 0.140 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2017 | 48 | 0.140 |
Why?
|
| Point-of-Care Systems | 2 | 2016 | 149 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2024 | 476 | 0.140 |
Why?
|
| Airway Obstruction | 1 | 1998 | 110 | 0.130 |
Why?
|
| Pulmonary Medicine | 1 | 2017 | 47 | 0.130 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 80 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 352 | 0.130 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 64 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1610 | 0.120 |
Why?
|
| Textbooks as Topic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 280 | 0.120 |
Why?
|
| Retrospective Studies | 10 | 2019 | 9398 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2019 | 554 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2015 | 117 | 0.120 |
Why?
|
| Attitude | 1 | 2015 | 131 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 2551 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2016 | 195 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 390 | 0.110 |
Why?
|
| Clinical Clerkship | 1 | 2014 | 118 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 1996 | 592 | 0.100 |
Why?
|
| Public Opinion | 2 | 2022 | 46 | 0.100 |
Why?
|
| Vena Cava Filters | 1 | 2013 | 86 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2014 | 325 | 0.100 |
Why?
|
| Young Adult | 3 | 2014 | 6520 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2015 | 597 | 0.090 |
Why?
|
| Device Removal | 1 | 2013 | 161 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2020 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 388 | 0.090 |
Why?
|
| Software | 2 | 2012 | 672 | 0.090 |
Why?
|
| Gastrostomy | 2 | 2001 | 69 | 0.090 |
Why?
|
| Acute Disease | 1 | 2012 | 853 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 2352 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 231 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 373 | 0.080 |
Why?
|
| Electromyography | 3 | 2000 | 195 | 0.080 |
Why?
|
| Mothers | 1 | 2011 | 147 | 0.080 |
Why?
|
| Vaccination | 1 | 2011 | 282 | 0.080 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 2 | 2019 | 59 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1066 | 0.080 |
Why?
|
| Hemodynamics | 3 | 2018 | 738 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1743 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 343 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 300 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2010 | 277 | 0.070 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 113 | 0.070 |
Why?
|
| Tattooing | 1 | 2007 | 5 | 0.070 |
Why?
|
| Body Piercing | 1 | 2007 | 6 | 0.070 |
Why?
|
| Traumatology | 1 | 2007 | 32 | 0.070 |
Why?
|
| Leadership | 2 | 2020 | 145 | 0.070 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 42 | 0.070 |
Why?
|
| Biomarkers | 1 | 2013 | 1822 | 0.070 |
Why?
|
| Portal Vein | 1 | 2006 | 121 | 0.060 |
Why?
|
| Hyperventilation | 1 | 2005 | 13 | 0.060 |
Why?
|
| Contrast Media | 1 | 2011 | 1084 | 0.060 |
Why?
|
| Brain Stem Neoplasms | 1 | 2005 | 17 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2018 | 8427 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 259 | 0.060 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 109 | 0.060 |
Why?
|
| Feasibility Studies | 3 | 2016 | 792 | 0.060 |
Why?
|
| Adolescent | 7 | 2014 | 9434 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 3722 | 0.050 |
Why?
|
| Probability | 1 | 2024 | 356 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 1756 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2006 | 239 | 0.050 |
Why?
|
| Lung Compliance | 2 | 2000 | 15 | 0.050 |
Why?
|
| Multimedia | 1 | 2022 | 9 | 0.050 |
Why?
|
| Venous Pressure | 1 | 2002 | 11 | 0.050 |
Why?
|
| Catheterization | 2 | 2001 | 237 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 93 | 0.050 |
Why?
|
| Educational Status | 1 | 2022 | 194 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 1900 | 0.050 |
Why?
|
| Respiratory Mechanics | 2 | 2000 | 103 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 98 | 0.050 |
Why?
|
| Prosthesis Failure | 1 | 2002 | 118 | 0.050 |
Why?
|
| Students | 1 | 2023 | 172 | 0.050 |
Why?
|
| Perception | 1 | 2022 | 181 | 0.050 |
Why?
|
| Colonic Diseases | 1 | 2001 | 61 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 119 | 0.050 |
Why?
|
| Cholangiography | 1 | 2001 | 42 | 0.050 |
Why?
|
| Bronchography | 1 | 2000 | 11 | 0.050 |
Why?
|
| Suction | 1 | 2000 | 36 | 0.040 |
Why?
|
| Nuclear Family | 2 | 2011 | 93 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2000 | 56 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2001 | 125 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 245 | 0.040 |
Why?
|
| Wakefulness | 1 | 2000 | 135 | 0.040 |
Why?
|
| Technology | 1 | 2020 | 32 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2000 | 371 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2002 | 337 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 1997 | 287 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 1999 | 44 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2001 | 251 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 130 | 0.040 |
Why?
|
| Transducers, Pressure | 1 | 1998 | 6 | 0.040 |
Why?
|
| Lung Volume Measurements | 2 | 2013 | 21 | 0.040 |
Why?
|
| Tidal Volume | 1 | 1998 | 55 | 0.040 |
Why?
|
| Tomography, Spiral Computed | 1 | 2018 | 77 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 627 | 0.040 |
Why?
|
| Acoustics | 1 | 1998 | 52 | 0.040 |
Why?
|
| Neck Muscles | 1 | 1997 | 17 | 0.040 |
Why?
|
| Mouth | 1 | 1997 | 48 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Myoepithelioma | 1 | 2017 | 11 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 23 | 0.040 |
Why?
|
| Bone and Bones | 1 | 1999 | 274 | 0.040 |
Why?
|
| France | 1 | 2017 | 49 | 0.030 |
Why?
|
| Parotid Gland | 1 | 2017 | 30 | 0.030 |
Why?
|
| Illinois | 1 | 2019 | 501 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 1996 | 18 | 0.030 |
Why?
|
| Neural Conduction | 1 | 1996 | 71 | 0.030 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2017 | 61 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1998 | 203 | 0.030 |
Why?
|
| Job Application | 1 | 2016 | 13 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 3033 | 0.030 |
Why?
|
| Thumb | 1 | 1996 | 23 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 5383 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 105 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 299 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 134 | 0.030 |
Why?
|
| School Admission Criteria | 1 | 2016 | 28 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 177 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2017 | 264 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2017 | 152 | 0.030 |
Why?
|
| Respiration | 1 | 1998 | 271 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2020 | 364 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 355 | 0.030 |
Why?
|
| Consumer Behavior | 1 | 2015 | 32 | 0.030 |
Why?
|
| Reaction Time | 1 | 1996 | 312 | 0.030 |
Why?
|
| Pyridines | 1 | 2017 | 305 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 3828 | 0.030 |
Why?
|
| Neural Pathways | 1 | 1996 | 320 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2015 | 74 | 0.030 |
Why?
|
| Edema | 1 | 2014 | 71 | 0.030 |
Why?
|
| Color | 1 | 2014 | 85 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 124 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2001 | 1181 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2014 | 208 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 616 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2014 | 471 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 73 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2013 | 4374 | 0.030 |
Why?
|
| Phlebography | 1 | 2013 | 66 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 642 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2014 | 592 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 500 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 442 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 300 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1807 | 0.030 |
Why?
|
| Pemetrexed | 1 | 2012 | 76 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1498 | 0.030 |
Why?
|
| Glutamates | 1 | 2012 | 89 | 0.030 |
Why?
|
| Fractals | 1 | 2012 | 42 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1217 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2012 | 128 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 115 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 2908 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 143 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 786 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2013 | 303 | 0.020 |
Why?
|
| Guanine | 1 | 2012 | 207 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2012 | 212 | 0.020 |
Why?
|
| Suburban Population | 1 | 2010 | 6 | 0.020 |
Why?
|
| Michigan | 1 | 2010 | 53 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 476 | 0.020 |
Why?
|
| Parity | 1 | 2010 | 97 | 0.020 |
Why?
|
| Fluoroscopy | 2 | 2001 | 132 | 0.020 |
Why?
|
| Cisplatin | 1 | 2012 | 602 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1195 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 240 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 228 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 27850 | 0.020 |
Why?
|
| Child | 2 | 2011 | 7291 | 0.020 |
Why?
|
| Mammography | 1 | 2010 | 470 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 20 | 0.020 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2006 | 35 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2344 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1563 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 3083 | 0.010 |
Why?
|
| Renal Veins | 1 | 2002 | 29 | 0.010 |
Why?
|
| Retreatment | 1 | 2002 | 106 | 0.010 |
Why?
|
| Vena Cava, Superior | 1 | 2002 | 60 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2002 | 97 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2001 | 30 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2002 | 220 | 0.010 |
Why?
|
| Needles | 1 | 2001 | 40 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2000 | 32 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 2000 | 19 | 0.010 |
Why?
|
| Sheep | 1 | 2000 | 250 | 0.010 |
Why?
|
| Stomach | 1 | 2000 | 111 | 0.010 |
Why?
|
| Equipment Design | 1 | 2000 | 418 | 0.010 |
Why?
|
| Respiratory Paralysis | 1 | 1997 | 8 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1997 | 66 | 0.010 |
Why?
|
| Electrodes | 1 | 1997 | 88 | 0.010 |
Why?
|
| Pressure | 1 | 1997 | 165 | 0.010 |
Why?
|
| Neck | 1 | 1997 | 104 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1997 | 190 | 0.010 |
Why?
|
| Oxygen | 1 | 2000 | 755 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 1897 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 3793 | 0.010 |
Why?
|